Newsletter | May 21, 2024

05.21.24 -- What Time Is Best To Bring My CDMO On Board?


Webinar: Optimizing the Path to First-in-Human Clinical Trials: An Integrated Approach to Design and De-risk Your Candidate

Join us on May 28th with Lonza to learn about the challenges that drug developers face in the early space. We’ll identify the pitfalls of suboptimal risk assessment and review an integrated approach to design and de-risking of early development candidates to streamline the path to GMP. Click here to learn more.


What Time Is Best To Bring My CDMO On Board?

The answer might be sooner than you think and entail more transparency than you're used to.

Navigating The Next Phase Of Biologics Through The CDMO Lens

Delve into the intricacies of biopharmaceutical innovation and cutting-edge insights in this e-book as a team of accomplished CDMO experts helps you navigate the complexities of biologics development.

The Source Of GMP: How Client Demand Drives Innovation

GMP-Source, which is a term we coined, serves the purpose as a highly qualified raw material for a generation of virus, messenger RNA template, and transgenic expression of proteins. 

Oncolytic Viruses Development And cGMP Manufacturing

Learn more about the leading oncolytic viruses, the leading cell lines, and how to strategize your oncolytic virus production plan.

Navigating A New Standard In Microbial Protein Expression

Recent advancements in genetic engineering, analytics, and screening reimagine E. coli as an “optimal” protein factory, not just a common one or an expression system artifact.

Ophthalmic Drug Delivery

Explore the challenges to effective delivery of drugs to the eye, intricacies of ophthalmic drug delivery, and advantages of nanoparticles as an enabling technology for ocular drug-delivery systems.

Development, Manufacture Of Biopharmaceuticals In Microbial Systems

We discuss the trends in new molecular formats, which are one of the current drivers of renewed interest in fermentation technologies, along with some of their challenges. 

Commercial Vs. Technical Priorities: The PM High-Wire Act

PMs must be technically adept enough to understand a project, but their main role is to ensure it delivers in terms of scope and budget.

A Proven AAV Platform To Drive Down Program Costs And Maximize Speed

To ensure that your adeno-associated virus (AAV) therapy reaches patients as soon as possible, begin your relationship with an experienced AAV manufacturer early in the development journey.

Accelerating cGMP Production Using Rapid Tech Transfer

A partnership between Cytiva and Teva Pharmaceuticals showcases tech transfer success through effective communication, diligent project management, and a wide range of expertise.


mAb And r-Proteins Contract Testing, Development, And Manufacturing Services - MilliporeSigma

Particle Control In Biopharmaceuticals - Lonza

Analytical Testing Capabilities - Comprehensive Cell Solutions, A Business Unit of NYBC Enterprises

Rising To Meet Increasing Demand For Microbial Based Biologics - Ajinomoto Bio-Pharma Services

Turbocharge Your Vaccine Development - Resilience US, Inc.

Link Your Antibody To Its Fullest Potential - Samsung Biologics

Contract Research Services For Drug Discovery And Development - Emulate

Get Your Biologic To Clinic And Market Faster - Catalent

Connect With Bioprocess Online: